Yamei Hu

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression.

Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression.

Journal: Cell death & disease

Published: September 09, 2025

PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.

PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.

Journal: Cellular & molecular biology letters

Published: September 08, 2025

Design, synthesis, and biological evaluation of novel 5,7,4'-trimethoxyflavone sulfonamide-based derivatives as highly potent inhibitors of LRPPRC/STAT3/CDK1.

Design, synthesis, and biological evaluation of novel 5,7,4'-trimethoxyflavone sulfonamide-based derivatives as highly potent inhibitors of LRPPRC/STAT3/CDK1.

Journal: Bioorganic chemistry

Published: August 09, 2024

RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters.

RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 05, 2024

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 08, 2023

PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras.

PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras.

Journal: Cellular and molecular life sciences : CMLS

Published: June 20, 2022

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Journal: Signal transduction and targeted therapy

Published: April 27, 2022

Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.

Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.

Journal: Clinical and translational medicine

Published: January 26, 2021

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo.

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 29, 2020

Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Journal: Oncogene

Published: October 12, 2020

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo.

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo.

Journal: Frontiers in cell and developmental biology

Published: September 07, 2020

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer.

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer.

Journal: Theranostics

Published: March 18, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026